Drug
Meclizine
Meclizine is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)
Phase Distribution
Ph phase_3
1
20%
Ph not_applicable
2
40%
Ph phase_2
1
20%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
N/A2 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin
NCT02112578
completednot_applicable
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
NCT02625181
completednot_applicable
Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
NCT00641797
completedphase_2
Meclizine as a Potential Smoking Cessation Treatment
NCT01443858
completedphase_1
The Effects of Antihistamines on Pre-Pulse Inhibition
NCT01537471
Clinical Trials (5)
Showing 5 of 5 trials
NCT02112578Phase 3
Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin
NCT02625181Not Applicable
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
NCT00641797Not Applicable
Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
NCT01443858Phase 2
Meclizine as a Potential Smoking Cessation Treatment
NCT01537471Phase 1
The Effects of Antihistamines on Pre-Pulse Inhibition
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5